本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Terns Pharmaceuticals, Inc.

52.88
-0.0400-0.08%
成交量:780.28萬
成交額:4.12億
市值:59.75億
市盈率:-51.25
高:52.96
開:52.93
低:52.83
收:52.92
52周最高:53.19
52周最低:1.87
股本:1.13億
流通股本:1.07億
量比:0.34
換手率:7.29%
股息:- -
股息率:- -
每股收益(TTM):-1.0319
每股收益(LYR):-1.1175
淨資產收益率:-29.12%
總資產收益率:-19.94%
市淨率:21.04
市盈率(LYR):-47.32

資料載入中...

2025/03/20

重要事件披露

Form 8-K - Current report
2025/02/24

重要事件披露

Form 8-K - Current report
2025/02/20

重要事件披露

Form 8-K - Current report
2025/02/06

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/06

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/16

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/12

重要事件披露

Form 8-K - Current report